Cygnus (www.cygn.com) develops, manufactures and commercializes new and improved glucose-monitoring devices. The Company's products are designed to provide more data to individuals and their physicians and enable them to make better-informed decisions on how to manage diabetes. The GlucoWatch® Biographer was Cygnus' first approved product. The device and its second-generation model are the only products approved by the FDA that provide frequent, automatic and non-invasive measurement of glucose levels. Cygnus believes its products represent the most significant commercialized technological advancement in self-monitoring of glucose levels since the advent of finger-stick blood glucose measurement approximately 20 years ago. The Biographer is not intended to replace the common finger-stick testing method, but is indicated as an adjunctive device to supplement blood glucose testing to provide more complete, ongoing information about glucose levels.
ProcterAndGamble; American Home Products; JV Wyeth-Ayerst; Ortho Pharmaceutical; Park Davis; Warner Lambert